Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11866495 Anti-CEACAM6 antibodies and uses thereof

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
January 29, 2020
0
Date of Patent
January 9, 2024
0
Patent Application Number
16776329
0
Patent Citations
‌
US Patent 8609089 Compositions of PD-1 antagonists and methods of use
0
‌
US Patent 8779108 Targeted binding agents against B7-H1
0
‌
US Patent 8900587 Antibodies to human programmed death receptor PD-1
0
‌
US Patent 10584167 Anti-CEACAM6 antibodies and uses thereof
0
‌
US Patent 7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
0
‌
US Patent 8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
0
‌
US Patent 8217149 Anti-PD-L1 antibodies, compositions and articles of manufacture
0
Patent Inventor Names
Simon Holton
0
Jörg Willuda
0
Christoph Freiberg
0
Uwe Gritzan
0
Julian Marius Glück
0
Frank Dittmer
0
Eva-Maria Gutierrez
0
Sven Golfier
0
Dorian Schönfeld
0
Philip Beckhove
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11866495
0
Patent Primary Examiner
‌
Sheela J. Huff
0
CPC Code
‌
A61K 39/001182
0

Find more entities like US Patent 11866495 Anti-CEACAM6 antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo